Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002122806 | SCV002408316 | benign | not provided | 2024-01-04 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002122806 | SCV004124326 | benign | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | ATP2B4: BS1, BS2 |
Breakthrough Genomics, |
RCV002122806 | SCV005281670 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003933447 | SCV004752622 | likely benign | ATP2B4-related disorder | 2019-07-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |